Acute posterior reversible encephalopathy syndrome (PRES) in setting of interferon-beta use: case presentation with reduction of edema in 72 h after cessation of interferon-beta therapy with sub-clinical inflammation

BACKGROUND: Posterior reversible encephalopathy syndrome (PRES) represents a transient change in mental status with associated vasogenic edema of cortical and subcortical brain structures. It is often attributed to multifactorial etiology including hypertension and altered hemodynamics and disruptio...

Descripción completa

Detalles Bibliográficos
Autores principales: Dietz, Nicholas, Mufti, Zarmina, Yousaf, Muhammed, Brown, Randal, Counts, Christopher, Bjurström, Martin F., Williams, Brian J., Robertson, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582210/
https://www.ncbi.nlm.nih.gov/pubmed/34758765
http://dx.doi.org/10.1186/s12883-021-02471-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582210/
https://www.ncbi.nlm.nih.gov/pubmed/34758765
http://dx.doi.org/10.1186/s12883-021-02471-7

Ejemplares similares